AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
EVH vs EVFM Fundamental Comparison
| Metric | EVH | EVFM |
|---|---|---|
| Revenue | $1.9B | $20.2M |
| Net Income | $-534.5M | $391,000.0 |
| Net Margin | -28.5% | 1.9% |
| ROE | -128.7% | N/A |
| ROA | -28.1% | 1.9% |
| Current Ratio | 1.31x | 0.18x |
| Debt/Equity | 2.34x | N/A |
| EPS | $-5.07 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EVH vs EVFM: Frequently Asked Questions
Is EVH or EVFM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. EVH is rated STRONG SELL (92% confidence) while EVFM is rated STRONG SELL (92% confidence). This is not investment advice.
How does EVH compare to EVFM fundamentally?
Evolent Health, Inc. has ROE of -128.7% vs Evofem Biosciences, Inc.'s N/A. Net margins are -28.5% vs 1.9% respectively.
Which stock pays higher dividends, EVH or EVFM?
EVH has a dividend yield of N/A or no dividend while EVFM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EVH or EVFM for long term?
For long-term investing, consider that EVH has STRONG SELL rating with 92% confidence, while EVFM has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EVH vs EVFM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EVH vs EVFM, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.